10 Most Profitable Cheap Stocks to Buy Now

6. Johnson & Johnson (NYSE:JNJ)

Forward P/E: 14.73

TTM Net Income: $21.81 Billion

Number of Hedge Fund Holders: 98

Johnson & Johnson (NYSE:JNJ) is an American multinational healthcare company that specializes in pharmaceuticals and medical technologies. The company is focused on medicine and MedTech to innovate and deliver breakthroughs in healthcare solutions. Johnson & Johnson (NYSE:JNJ) ranks among the most profitable stocks to buy now.

During the first quarter of 2025, the company made good progress in its research and product development and advanced its pipeline with new developments like TREMFYA for inflammatory bowel disease, RYBREVANT plus LAZCLUZE for non-small-cell lung cancer, and OTTAVA, a soft tissue surgical robotic system. Additionally, Johnson & Johnson (NYSE:JNJ) further enhanced its neuroscience portfolio through the acquisition of Intra-Cellular Therapies. In March 2025, the company announced plans to invest more than $55 billion in the US over the next four years. Johnson & Johnson (NYSE:JNJ) is focused on driving innovation and maintaining its leadership in medical technology. The investment will be used to build three new advanced manufacturing facilities and expand several existing sites across the company’s Innovative Medicine and MedTech businesses. Increased investments in technology will help Johnson & Johnson (NYSE:JNJ) speed up drug discovery and development, support workforce training, and improve business operations.